Can J Emerg Med
-
Randomized Controlled Trial
Ondansetron for pediatric concussion; a pilot study for a randomized controlled trial.
Assess the feasibility of a study evaluating one dose of oral ondansetron to decrease post-concussion symptoms at one week and one month following concussion in children aged 8 to 17 years old. ⋯ In our study population, approximately one-third of the screened concussion patients were eligible to participate and approximately one half of those eligible agreed to participate. Our study found that most enrolled patients preferred electronic follow-up; the noncompliance rate was minimal.